Journal list menu
Biochemical and Cellular Effects of Roscovitine, a Potent and Selective Inhibitor of the Cyclin-Dependent Kinases cdc2, cdk2 and cdk5
Corresponding Author
Laurent Meijer
CNRS, Station Biologique, BP 74, Roscoff, France
L. Meijer, CNRS, Station Biologique, BP 74, F-29682 Roscoff cedex. France Fax:+33 2 98 29 23 42. E-mail: [email protected]Search for more papers by this authorJames P. J. Chong
Imperial Cancer Research Fund, Clare Hall Laboratories, Potter's Bar, UK
Search for more papers by this authorJ. Julian Blow
Imperial Cancer Research Fund, Clare Hall Laboratories, Potter's Bar, UK
Search for more papers by this authorNaoyuki Inagaki
Department of Neurophysiology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
Search for more papers by this authorMasaki Inagaki
Department of Neurophysiology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
Search for more papers by this authorJean-Guy Delcros
URA CNRS 1529, Faculté de Médecine, Rennes, France
Search for more papers by this authorJacques-Philippe Moulinoux
URA CNRS 1529, Faculté de Médecine, Rennes, France
Search for more papers by this authorCorresponding Author
Laurent Meijer
CNRS, Station Biologique, BP 74, Roscoff, France
L. Meijer, CNRS, Station Biologique, BP 74, F-29682 Roscoff cedex. France Fax:+33 2 98 29 23 42. E-mail: [email protected]Search for more papers by this authorJames P. J. Chong
Imperial Cancer Research Fund, Clare Hall Laboratories, Potter's Bar, UK
Search for more papers by this authorJ. Julian Blow
Imperial Cancer Research Fund, Clare Hall Laboratories, Potter's Bar, UK
Search for more papers by this authorNaoyuki Inagaki
Department of Neurophysiology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
Search for more papers by this authorMasaki Inagaki
Department of Neurophysiology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
Search for more papers by this authorJean-Guy Delcros
URA CNRS 1529, Faculté de Médecine, Rennes, France
Search for more papers by this authorJacques-Philippe Moulinoux
URA CNRS 1529, Faculté de Médecine, Rennes, France
Search for more papers by this authorAbstract
Cyclin-dependent kinases (cdk) play an essential role in the intracellular control of the cell division cycle (cdc). These kinases and their regulators are frequently deregulated in human tumours. Enzymatic screening has recently led to the discovery of specific inhibitors of cyclin-dependent kinases, such as butyrolactone I, flavopiridol and the purine olomoucine. Among a series of C2, N6, N9-substituted ade-nines tested on purified cdc2/cylin B, 2-(1-ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpu-rine (roscovitine) displays high efficiency and high selectivity towards some cyclin-dependent kinases. The kinase specificity of roscovitine was investigated with 25 highly purified kinases (including protein kinase A, G and C isoforms, myosin light-chain kinase, casein kinase 2, insulin receptor tyrosine kinase, c-src, v-abl). Most kinases are not significantly inhibited by roscovitine. cdc2/cyclin B, cdk2/cyclin A, cdk2/cyclin E and cdkSlp35 only are substantially inhibited (IC50 values of 0.65, 0.7, 0.7 and 0.2 μM, respectively). cdk4/cyclin D1 and cdk6/cyclin D2 are very poorly inhibited by roscovitine (IC50>100 μM). Extracellular regulated kinases erkl and erk2 are inhibited with an IC50 of 34 μM and 14 μM, respectively. Roscovitine reversibly arrests starfish oocytes and sea urchin embryos in late pro-phase. Roscovitine inhibits in vitro M-phase-promoting factor activity and in vitro DNA synthesis in Xenopus egg extracts. It blocks progesterone-induced oocyte maturation of Xenopus oocytes and in vivo phosphorylation of the elongation factor eEF-1. Roscovitine inhibits the proliferation of mammalian cell lines with an average IC50] of 16 μM. In the presence of roscovitine L1210 cells arrest in G1 and accumulate in G2. In vivo phosphorylation of vimentin on Ser55 by cdc2/cyclin B is inhibited by roscovitine. Through its unique selectivity for some cyclin-dependent kinases, roscovitine provides a useful anti-mitotic reagent for cell cycle studies and may prove interesting to control cells with deregulated cdc2, cdk2 or cdk5 kinase activities.
Abbreviations
-
- cdc
-
- cell division cycle
-
- cdk
-
- cyclin-dependent kinase
-
- erkl and erk2
-
- extracellular regulated kinase 1 and 2
-
- 1MeAde
-
- 1-methyladenine
-
- MPF
-
- M-phase promoting factor
-
- [Ser(P)55]vimentin
-
- vimentin phosphorylated on Ser55; NCI, National Cancer Institute (USA)
References
- 1 Murray, A. & Hunt, T. (1993) in The cell cycle-an introduction, W. H. Freeman and Company, New York .
- 2 P. Fantes & R. Brooks (editors) (1994) in The cell cycle- a practical approach, IRL Press, Oxford .
- 3 D. Glover, A. Hall & N. Hastie (eds) (1994) J. Cell Sci. Suppl. 18.
- 4 V. W. Hu (ed.) (1994) in The cell cyle. Regulators, turgets, and clinical applicafions, Plenum Press, New York .
- 5
L. Meijer,
S. Guidet &
H. Y. L. Tung (eds) (1995) in
Progress in cell cycle research, vol. 1, Plenum Press,
New York
.
10.1007/978-1-4615-1809-9_29 Google Scholar
- 6 Grana, X. & Reddy, E. P. (1995) Oncogene 11, 211–219.
- 7 Gould, K. L. (1995) in Protein kinases ( J. R. Woodget, ed.) ch. 5, pp. 149–176, IRL Press, Oxford .
- 8 Morgan, D. O. (1995) Nature 374, 131–134.
- 9 Pines, J. (1995) Biochem. J. 308, 697–711.
- 10 Van den Heuvel, S. & Harlow, E. (1993) Science 262, 2050–2054.
- 11 De Bondt, H. L., Rosenblatt, J., Jancarik, J., Jones, H. D., Morgan, D. O. & Kim, S. H. (1993) Nature 363, 595–602.
- 12 Jeffrey, P. D., Russo, A. A., Polyak, K., Gibbs, E., Hurwitz, J., Massagué, J. & Pavletich, N. P. (1995) Nature 376, 313–320.
- 13 Cordon-Cardo, C. (1995) Am. J. Pathol. 147, 545–560.
- 14 Karp, J. E. & Broder, S. (1995) Nat. Med. 1, 309–320.
- 15 Yang, Z. Y., Perkins, N. D., Ohno, T., Nabel, E. G. & Nabel, G. J. (1995) Nat. Med. 1, 1052–1056.
- 16 Rialet, V. & Meijer, L. (1991) Anticancer Res. 11, 1581–1590.
- 17 Gadbois, D. M., Hamaguchi, J. R., Swank, R. A. & Bradbury, E. M. (1992) Biochem. Biophys. Res. Commun. 184, 80–85.
- 18 Kitagawa, M., Okabe, T., Ogino, H., Matsumoto, H., Snzuki-Taka-hashi, I., Kokubo, T., Higashi, H., Saitoh, S., Taya, Y., Yasuda, H., Ohba, Y., Nishimura, S., Tanaka, N. & Okuyama, A. (1993) Oncogene 8, 2425–2432.
- 19 Kitagawa, M., Higashi, H., Suzuki-Takahashi, I., Okabe, T., Ogino, H., Taya, Y., Nishimura, S. & Okuyama, A. (1994) Oncogene 9, 2549–2557.
- 20 Someya, A., Tanaka, N. & Okuyama, A. (1994) Biochem. Biophys. Res. Commun. 198, 536–545.
- 21 Kaur, G., Stetler-Stevenson, M., Sebers, S., Worland, P., Sedlacek, H., Myers, C., Czech, J., Naik, R. & Sausville, E. (1992) J. Natl Cancer Inst. 84, 1736–1740.
- 22 Worland, P. J., Kaur, G., Stetler-Stevenson, M., Sebers, S., Sartor, O. & Sausville, E. A. (1993) Biochem. Pharmacol. 46, 1831–1840.
- 23 Losiewiecz, M. D., Carlson, B. A., Kaur, G., Sausville, E. A. & Worland, P. J. (1994) Biochem. Biophys. Res. Commun. 201, 589–595.
- 24 Bojanowski, K., Nishio, K., Fukuda, M., Larsen, A. K. & Saijo, N. (1994) Biochem. Biophys. Res. Commun. 203, 1574–1580.
- 25 Parker, C. W., Entsch, B. & Letham, D. S. (1986) Phytochemistry 25, 303–310.
- 26 Glab, N., Labidi, H., Qin, L.-X., Trehin, C., Bergounioux, C. & Meijer, L. (1994) FEBS Lett. 353, 207–214.
- 27 Vesely, J., Havlicek, L., Stmad, M., Blow, J. J., Donella-Deana, A., Pinna, L., Letham, D. S., Kato, J. Y., Détivaud, L., Leclerc, S. & Meijer, L. (1994) Eur. J. Biochem. 224, 771–786.
- 28 Abraham, R. T., Acquarone, M., Andersen, A., Asensi, A., Bellé, R., Berger, F., Bergounioux, C., Brunn, G., Buquet-Fagot, C., Fagot, D., Glab, N., Goudeau, H., Goudeau, M., Guerrier, P., Houghton, P. J., Hendriks, H., Kloareg, B., Lippai, M., Marie, D., Maro, B., Meijer, L., Mester, J., Mulner-Lorillon, O., Poulet, S. A., Schierenberg, E., Schutte, B., Vaulot, D. & Verlhac, M. H. (1995) Biol. Cell 83, 105–120.
- 29
Meijer, L., (1995) in
Progress in cell cycle research ( L. Meijer,
S. Guidet &
H. Y. L. Tung, eds) vol. 1, pp.
351–363, Plenum Press,
New York
.
10.1007/978-1-4615-1809-9_29 Google Scholar
- 30 Meijer, L. (1996) Trends Cell Biol. 6, 393–397.
- 31 Schulze-Gahmen, U., Brandsen, J., Jones, H. D., Morgan, D. O., Meijer, L., Vesely, J. & Kim, S. H. (1995) Proteins: Struct. Funct. Genet. 22, 378–391.
- 32 Ongkeko, W., Ferguson, D. J. P., Harris, A. L. & Norbury, C. (1995) J. Cell Sci. 108, 2897–2904.
- 33 Park, D. S., Farinelli, S. E. & Greene, L. A. (1996) J. Biol. Chem. 271, 8161–8169.
- 34 Azevedo, W. F. Jr, Leclerc, S., Meijer, L., Havlicek, L., Strnad, M. & Kim, S. H. (1997) Eur. J. Biochem. 243, 518–526.
- 35 Azzi, L., Meijer, L., Ostvold, A. C., Lew, J. & Wang, J. H. (1994) J. Biol. Chem. 269, 13279–13288.
- 36 Baratte, B., Meijer, L., Galaktionov, K. & Beach, D. (1992) Anticancer Res. 12, 873–880.
- 37 Richardson, H. E., Stueland, C. S., Thomas, J. & Reed, S. I. (1990) Genes Dev 4, 1332–1344.
- 38 Lew, J., Beaudctte, K., Litwin, C. M. E. & Wang, J. H. (1992) J. Biol. Chem. 267, 13383–13390.
- 39 Meyerson, M. & Harlow, E. (1994) Mol. Cell. Biol. 14, 2077–2086.
- 40 Charest, D. L., Mordret, G., Harder, K. W., Jirik, F. & Pelech, S. L. (1993) Mol. Cell. Biol. 13, 4679–4690.
- 41 Bianchi, M. W., Guivarc'h, D., Thomas, M., Woodgett, J. R. & Kreis, M. (1994) Mol. Gen. Genet. 242, 337–345.
- 42 Kallen, R. G., Smith, J. E., Sheng, Z. & Tung, H. Y. L. (1990) Biochem. Biophys. Res. Commun. 168, 616–624.
- 43 Pondaven, P., Meijer, L. & Beach, D. (1990) Genes Dev. 4, 9–17.
- 44 Blow, J. J. & Laskey, R. A. (1986) Cell 47, 577–587.
- 45 Blow, J. J. (1993) J. Cell Biol. 122, 993–1002.
- 46 Mulner-Lorillon, O., Minella, O., Cormier, P., Capony, J.-C., Cavadore, J.-C., Morales, J., Poulhe, R. & Bellé, R. (1994) J. Biol. Chem. 269, 20201–20207.
- 47 Grever, M. R., Schepartz, S. A. & Chabner, B. A. (1992) Semin. Oncol. 19, 622–638.
- 48 Scudiero, D. A., Shoemaker, R. H., Paull, K. D., Monks, A., Tierney, S., Nofziger, T. H., Currens, M. J., Seniff, D. & Boyd, M. R. (1988) Cuncer Res. 48, 4827–4833.
- 49 Basu, H. S., Sturkenboom, M. C. J. M., Delcros, J. G., Csokan, P. P., Szollosi, J., Feuerstein, B. G. & Marton, L. J. (1992) Biochem. J. 282, 723–727.
- 50 Tsujimura, K., Ogawara, M., Takeuchi, Y., Imajoh-Ohmi, S., Ha, M. H. & Inagaki, M. (1994) J. Biol. Chem. 269, 31097–31106.
- 51 Meijer, L. & Mordret, G. (1994) Semin. Dev. Biol. 5, 165–171.
- 52 Izumi, T. & Maller, J. L. (1995) Mol. Biol. Cell 6, 215–226.
- 53 Hoffmann, I. & Karsenti, E. (1994) J. Cell Sci. Suppl. 18, 75–79.
- 54 Strausfeld, U., Fernandez, A., Capony, J. P., Girard, F., Lautredou, N., Derancourt, J., Labbe, J. C. & Lamb, N. J. C. (1994) J. Biol. Chem. 269, 5989–6000.
- 55 Tang, Z., Coleman, T. R. & Dunphy, W. G. (1993) EMBO J. 12. 3427–3436.
- 56 McGowan, C. H. & Russell, P. (1995) EMBO J. 14, 2166–2175.
- 57 Mueller, P. R., Coleman, T. R. & Dunphy, W. G. (1995) Mol. Biol. Cell 6, 119–134.
- 58 Parker, L. L., Sylvestre, P. J., Byrnes III, M. J., Liu, F. & Piwnica-Worms (1995) Proc. Natl Acad. Sci. USA 92, 9638–9642.
- 59 Watdnabe, N., Broomc, M. & Hunter, T. (1995) EMBO J. 14, 1878–1891.
- 60 Meyerson, M., Enders, G. H., Wu, C. L., Su, L. K., Gorka, C., Nelson, C., Harlow, E. & Tsai, L. H. (1992) EMBO J. 11, 2909–2917.
- 61 Misteli, T. & Warren, G. (1995) J. Cell Sci. 108, 2715–2727.
- 62 Rudolph, B., Saffrich, R., Zwicker, J., Henglein, B., Muller, R., Ansorge, W. & Eilers, M. (1996) EMBO J. 15, 3065–3076.
- 63 Lorca, T., Labbé, J. C., Devault, A., Fesquet, D., Strausfeld, U., Nilsson, J. Nygren, P. A., Whlen, M., Cavadore, J. C. & Dorée, M. (1992) J. Cell Sci. 102, 55–62.
- 64 Lahavbaratz, S., Sudakin, V., Ruderman, J. V. & Hershko, A. (1995) Proc. Natl Acad. Sci. USA 92, 9303–9307.
- 65 Lowe, S. W., Ruley, H. E., Jacks, T. & Housman, D. E. (1993) Cell 74, 957–967.
- 66 Fisher, D. E. (1994) Cell 78, 539–542.
- 67 Smets, L. A. (1994) Anti-Cancer Drugs 5, 3–9.
- 68 Darzynhewicz, Z. (1995) J. Cell. Biochem. 58, 151–159.
- 69
Hensey, C. &
Gautier, J. (1995) in
Progress in cell cycle research ( L. Meijer,
S. Guidet &
H. Y. L. Tung, eds) vol. 1, pp.
149–162, Plenum Press,
New York
.
10.1007/978-1-4615-1809-9_12 Google Scholar
- 70 Kondo, S. (1995) J. Radiat. Res. 36, 56–62.
- 71 Enoch, T. & Norbury, C. (1995) Trends Biochem. Sci. 20, 426–430.
- 72 Meikrantz, W., Gisselbrecht, S., Tam, S. W. & Schlegel, R. (1994) Proc. Natl Acad. Sci. USA 91, 3754–3758.
- 73 Shi, L., Nishioka, W. K., Th'ng, J., Bradbury, E. M., Litchfield, D. W. & Greenberg, A. H. (1994) Science 263, 1143–1145.
- 74 Fotedar, R. Flatt, J., Gupta, S., Margolis, R. L., Fittzgerald, P., Messier, H. & Fotedar, A. (1995) Mol. Cell. Biol. 15, 932–942.
- 75 Lazebnik, Y. A., Cole, S., Cooke, C. A., Nelson, W. G. & Earnshaw, W. C. (1993). J. Cell Biol. 123, 7–22.
- 76 Norbury, C., MacFarlane, M., Fearnhead, H. & Cohen, G. M. (1994) Biochem. Biophys. Res. Commun. 202, 1400–1406.
- 77 Oberhammer, F. A., Hochegger, K., Froschl, G., Tiefenbacher, R. & Pdvelka, M. (1994) J. Cell Biol. 126, 827–837.
- 78 Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L. & Wyllie, A. H. (1993) Nature 362, 849–852.
- 79 Yonish-Rouach, E., Grunwald, D., Wilder, S., Kimchi, A., May, E., Lawrence, J. J., May, P. & Oren, M. (1993) Mol. Cell. Biol. 13, 1415–1423.
- 80 Allday, M. J., Inman, G. J., Crawford, D. H. & Farrell, P. J. (1995) EMBO J. 14, 4994–5005
- 81 Strasser, A., Harris, A. W., Jacks, T. & Cory, S. (1994) Cell 79, 329–339.
- 82 Han, Z., Chatterjee, D., He, D. M., Early, J., Pantazis, P., Wyche, J. H. & Hendrickson, E. A. (1995) Mol. Cell. Biol. 15, 5849–5857.
- 83 Woods, C. M., Zhu, J., McQueney, P. A., Bollag, D. & Lazarides, E. (1995) Mol. Med. 1, 506–526.
- 84 Mandelkow, E. M. & Mandelkow, E. (1993) Trends Biochem. Sci. 18, 480–483.
- 85 Morishima-Kawashima, M., Hasegawa, M., Takio, K., Suzuki, M., Yoshida, F., Titani, K. & Ihara, Y. (1995) J. Biol. Chem. 270, 823–829.
- 86 Lew, J. & Wang, J. H. (1995) Tred Biochem. Sci. 20, 33–37.
Citing Literature
